Trevi Therapeutics Inc (TRVI) Kompaniya qiymatining sof foydaga nisbati
Neyrogen qichishish va yo'tolni davolashdagi patentlar uchun kurash Trevi Therapeutics (TRVI) kompaniyasining rivojlanish trayektoriyasini belgilaydi, bu esa nalbuphine ER ni chiqarish uchun tadqiqot va ishlanmalar (R&D) zanjirini rag'batlantiradi. Kompaniyaning choraklik P/E ko'rsatkichi klinik muvaffaqiyatga bo'lgan ushbu bog'liqlikni vizuallashtiradi, bunda -32.30 ushbu parametrning qiymatini ko'rsatadi. Surunkali patologiyalarga chalingan bemorlarga yo'naltirilgan dori vositalarining uzoq muddatli sotuv istiqbollari yakunda ushbu biznes modelining fundamental barqarorligini tasdiqlaydi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_TRVI_-_Trevi-Therapeutics_-_PE-Multiple "TRVI: trevitherapeutics.com Kapitalizatsiyaning foydaga nisbati 04.07.2022 - 15.11.2026 | 👁️GURU.Markets👁️")
Trevi Therapeutics (TRVI) kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Trevi Therapeutics|TRVI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Trevi Therapeutics, Inc.|TRVI - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Trevi Therapeutics Inc|TRVI - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Trevi Therapeutics|Shoshilinch likvidlik trevitherapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
TRVI - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Trevi Therapeutics|TRVI - P/E multiplikatori|Forvard P/E multiplikatori Trevi Corp|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Trevi Therapeutics Inc|TRVI - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Trevi Therapeutics|TRVI - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi trevitherapeutics.com|TRVI - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Trevi Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:Trevi Therapeutics, Inc., TRVI
P/E koeffitsiyenti sof foydaning bir birligi xarajatini aks ettiradi va bu investorga aktivning haqiqiy daromadlariga nisbatan qanchalik haddan tashqari baholanganligini aniqlash imkonini beradi. Trevi Therapeutics (TRVI) kompaniyasining P/E vaqtlar ketma-ketligini tahlil qilish orqali, qichishish va yo'tashga qarshi dori vositalarini tijoratlashtirish bo'yicha bozor kutuvlarini kompaniyaning joriy daromadliligi bilan solishtirish mumkin, bu esa biotexnologiya sektoridagi investitsiyalarning barqarorligini baholash uchun juda muhimdir.
Muhim raqobatchilar
Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Narxning foydaga nisbati|CBLL: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRTA (prothena.com)|Alector, Inc. (ALEC) - Narxning foydaga nisbati|Narx-foyda multiplikatori ANNX|Narxning foydaga nisbati Omeros Corp.|Neurogene Therapeutics (NGNE) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ACIU|VYGR (Voyager Therapeutics) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NMRA (neumoratx.com)|SCLX: Narx-foyda multiplikatori|TVGN - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Alpha Cognition Inc.|CGTX: P/E multiplikatori|inhibikase.com (IKT) - P/E multiplikatori|Narxning foydaga nisbati Cassava Sciences Inc|ASRT - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati Coya (COYA)|P/E multiplikatori VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - P/E multiplikatori|Biznesning o‘zini qoplash muddati alteritytherapeutics.com ATHE|CLNN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati PepGen Corp (PEPG)|Narxning foydaga nisbati Jupiter Neurosciences, Inc.|RLMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ANVS|Narx-foyda koeffitsiyenti Grace Tx GRCE|Narxning foydaga nisbati Firefly Neuroscience, Inc AIFF|KLTO: Narx-foyda multiplikatori|NRSN - Narxning foydaga nisbati|RVPH: Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narx-foyda koeffitsiyenti|NeurAxis Inc. (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical|Passage Bio, Inc. - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti NEUP (Neuphoria)|NERV - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ATHA (athira.com)|P/E multiplikatori Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - P/E multiplikatori|CYCN - P/E multiplikatori|PTIX (Protagenic Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Pasithea (KTTA)|Narxning foydaga nisbati Cortigent|Kapitalizatsiyaning foydaga nisbati Avenue Therapeutics Inc. ATXI|Narxning foydaga nisbati brainstorm-cell.com (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics, Inc CARA|P/E multiplikatori CHRO (chromocell.com)|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori
